CVS Health (CVS) PT Raised to $115 at BofA Securities
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $97.16 +2.28%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Michael Cherny raised the price target on CVS Health (NYSE: CVS) to $115.00 (from $112.00) while maintaining a Buy rating.
You May Also Be Interested In
- CVS Health (CVS) PT Raised to $118 at JPMorgan
- Evercore reports July prescription volumes up 1.9% year-over-year
- New study from CVS Caremark and Employee Benefit News shows how employers rely on their pharmacy benefit manager to create sustainable pharmacy solutions
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
